Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04604093 · ClinicalTrials.gov registry record
Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemia in People With T2 Diabetes
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 358
- Enrollment target
NCT04604093: Completed study, sponsored by Abbott Diabetes Care.
NCT04604093 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 358 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04604093 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 358 participants
- Enrollment target
Study Summary
A multi-center, randomized, prospective, non-significant risk study to compare the impact of the FreeStyle Libre 2 Flash Glucose Monitoring System to the current standard of care (SMBG, self-monitoring of blood glucose) on reducing time above 180 mg/dL in subjects with type 2 diabetes who are not adequately controlled on their existing oral anti-diabetes medication regimen.
Primary Outcome
To assess the impact of the FreeStyle Libre 2 Flash Glucose Monitoring System on time above 180 mg/dL in subjects with type 2 diabetes who are not adequately controlled on their existing oral anti-diabetes medication regimen when compared to the current standard of care (SMBG, self-monitoring of blood glucose).
Interventions
- DEVICE SMBG Meter
- DEVICE FreeStyle Libre 2 System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2023-03-30 |
What the finished NCT04604093 record still lists
NCT04604093 is an observational study that tracks outcomes without assigning an intervention. The registered 358 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which SMBG Meter is the first listed.
NCT04604093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04604093 about?
NCT04604093 is a clinical study titled "Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemia in People With T2 Diabetes". A multi-center, randomized, prospective, non-significant risk study to compare the impact of the FreeStyle Libre 2 Flash Glucose Monitoring System to the current standard of care (SMBG, self-monitoring of blood glucose) on reducing time above 180 mg/dL in subjects with type 2 diabetes who are not ad...
What is the current status of trial NCT04604093?
This trial is currently completed. The enrollment target is 358 participants. The study started on 2020-10-20. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT04604093?
The interventions under investigation include: SMBG Meter (DEVICE), FreeStyle Libre 2 System (DEVICE).
Who is sponsoring clinical trial NCT04604093?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04373317 · 358 participants · Phase 4
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- NCT05684965 · 358 participants · Phase 1
XTX301 in Patients With Advanced Solid Tumors
- NCT05824975 · 358 participants · Phase 1
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- NCT06480227 · 358 participants · NA
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI